|

Evaluation of Heart Failure Telemonitoring Eligibility Criteria

RECRUITINGSponsored by University Hospital, Clermont-Ferrand
Actively Recruiting
SponsorUniversity Hospital, Clermont-Ferrand
Started2025-12-05
Est. completion2026-12
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07278583

Summary

CARDIAUVERGNE is a heart failure telemonitoring system at Clermont-Ferrand's hospital. The aim of this study is to analyze the prognosis and evolution of patients after exclusion of telemonitoring. The patients were included from 1st January 2023 to 31st December 2024 and the monitoring was terminated for end of eligibility according to the French health authority criteria.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* adults
* able to read and understand french
* included in CARDIAUVERGNE telemonitoring program from 1st january 2023 to 31st december 2024 such as defined by the french health authorithy criteria (heart failure within 12 months or dyspnea at least NYHA 2 associated with NTproBNP of at least 1000pg/mL) and excluded by medical decision as no longer presenting eligibillity criteria

Exclusion Criteria:

* Patients leaving telemonitoring for other reasons (choice, death, medical reason, relocation, inobservance)

Conditions2

Heart DiseaseHeart Failure

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.